mifepristone has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, JE; Bartlett, TE; Boggavarapu, NR; Clarke, RB; Dubeau, L; Evans, DG; Evans, I; Gemzell-Danielsson, K; Ghezelayagh, TS; Haran, S; Herzog, C; Howell, SJ; Jones, A; Jones, L; Lalitkumar, PG; Papaikonomou, K; Pashayan, N; Ponandai-Srinivasan, S; Rådestad, AF; Reisel, D; Risques, RA; Simões, BM; Widschwendter, M | 1 |
| Chen, C; Chen, CH; Chen, H; Liang, H; Liu, R; Liu, S; Yang, C; Zhao, P; Zhi, X; Zhou, Z | 1 |
| Cai, Y; Conzen, SD; Goyal, A; Hall, BA; Kocherginsky, M; Skor, MN; Wonder, EL | 1 |
| Chen, C; Chen, H; Chen, W; Dong, C; Liang, H; Liu, R; Liu, S; Nie, Z; Shi, P; Yang, R; Zhou, Z | 1 |
1 trial(s) available for mifepristone and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women.
Topics: Breast Neoplasms; Epigenesis, Genetic; Female; Humans; Mifepristone; Mutation; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Triple Negative Breast Neoplasms | 2022 |
3 other study(ies) available for mifepristone and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Mifepristone Derivative FZU-00,003 Suppresses Triple-negative Breast Cancer Cell Growth partially via miR-153-KLF5 axis.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Female; Humans; Kruppel-Like Transcription Factors; MicroRNAs; Mifepristone; Triple Negative Breast Neoplasms | 2020 |
Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Line, Tumor; Dexamethasone; Drug Resistance, Neoplasm; Dual Specificity Phosphatase 1; Female; Gene Expression; Hormone Antagonists; Humans; Immediate-Early Proteins; Mice; Mice, SCID; Mifepristone; Neoplasm Recurrence, Local; Neoplasm Transplantation; Paclitaxel; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Receptors, Estrogen; Receptors, Glucocorticoid; Signal Transduction; Transplantation, Heterologous; Triple Negative Breast Neoplasms | 2013 |
Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Disease Models, Animal; Gene Expression; Heterografts; Humans; Kruppel-Like Transcription Factors; Mice, Inbred NOD; Mice, SCID; MicroRNAs; Mifepristone; Stem Cells; Treatment Outcome; Triple Negative Breast Neoplasms | 2016 |